Virological and Immunological Responses to Raltegravir and Dolutegravir in the Gut-Associated Lymphoid Tissue of HIV-Infected Men and Women
Antiviral Therapy · 2018-08 · 23 (6) · 495-504
DOI: 10.3851/imp3236 ↗At a glance
Klinische Studie (Phase IV) in Antiviral Therapy, published online on 2017-08-01. Written by Michael D Weber and 12 co-authors. Institution: University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA. Cited 10 times so far (Crossref); 35 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NCATS NIH HHS.
Abstract (original language)
Background
Raltegravir (RTG) and dolutegravir (DTG) have different pharmacokinetic patterns in the gastrointestinal tract. To determine if this results in pharmacodynamic differences, we compared HIV RNA, HIV DNA and immunological markers in gut-associated lymphoid tissue (GALT) of HIV-infected participants receiving RTG or DTG with tenofovir+emtricitabine (TDF/FTC).
Methods
GALT specimens from the terminal ileum, splenic flexure and rectum were obtained by colonoscopy at a single time point in 20 adults treated with RTG ( n=10) or DTG ( n=10) with HIV RNA
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- University of North Carolina Eshelman School of Pharmacy, Chapel Hill, NC, USA.
- Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
- Department of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
- Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Funding
- NIAID NIH HHS
- NCATS NIH HHS
Cite
APA
Weber, M. D., Andrews, E., Prince, H. A., Sykes, C., Rosen, E. P., Bay, C., Shaheen, N. J., Madanick, R. D., Dellon, E. S., De Paris, K., Nelson, J. A., Gay, C. L., & Kashuba, A. D. (2018). Virological and Immunological Responses to Raltegravir and Dolutegravir in the Gut-Associated Lymphoid Tissue of HIV-Infected Men and Women. Antiviral Therapy, 23(6), 495-504. https://doi.org/10.3851/imp3236
Vancouver
Weber MD, Andrews E, Prince HA, Sykes C, Rosen EP, Bay C, et al. Virological and Immunological Responses to Raltegravir and Dolutegravir in the Gut-Associated Lymphoid Tissue of HIV-Infected Men and Women. Antiviral Therapy. 2018;23(6):495-504. doi:10.3851/imp3236
BibTeX
@article{Weber2018,
author = {Weber, Michael D and Andrews, Elizabeth and Prince, Heather A and Sykes, Craig and Rosen, Elias P and Bay, Camden and Shaheen, Nicholas J and Madanick, Ryan D and Dellon, Evan S and De Paris, Kristina and Nelson, Julie Ae and Gay, Cynthia L and Kashuba, Angela Dm},
title = {Virological and Immunological Responses to Raltegravir and Dolutegravir in the Gut-Associated Lymphoid Tissue of HIV-Infected Men and Women},
journal = {Antiviral Therapy},
year = {2018},
volume = {23},
number = {6},
pages = {495--504},
doi = {10.3851/imp3236}
}
EUVIMED